Advertisement

Archives of Gynecology and Obstetrics

, Volume 243, Issue 2, pp 111–114 | Cite as

Experience with the treatment of metastatic ovarian carcinoma

  • K. Shiromizu
  • T. Kawana
  • M. Sugase
  • R. Izumi
  • M. Mizuno
Originals

Summary

Metastases from non-genital sites comprise about one in six of our malignant ovarian tumors. The mean age of our 24 patients with such metastases was 43.1 years and 81% had bilateral ovarian metastases. Out of the 24 patients we studied, 21 had a gastric primary. The overall survival rate was 41.7% in 6 months, 25.0% in 1 year and 12.5% in 2 years. Patients with no extraovarian metastases had a survival rate of 75.0% at 6 moths, 62.5% at 1 year and 25.0% at 2 years after operation.

Key words

Metastatic ovarian carcinoma Extraovarian spread Prognosis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hale RW (1968) Krukenberg tumor of the ovaries: a review of 81 records. Obstet Gynecol 32: 221–225Google Scholar
  2. 2.
    Israel SL, Helsel EW jr, Hausman DH (1965) The challenge of metastatic ovarian carciroma. Am J Obstet Gynecol 93: 1094–1101Google Scholar
  3. 3.
    Johansson H (1960) Clinical aspects of metastatic ovarian cancer of extragenital origin. Acta Obst Gynecol Scand 39: 681–697Google Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • K. Shiromizu
    • 1
  • T. Kawana
    • 1
  • M. Sugase
    • 1
  • R. Izumi
    • 1
  • M. Mizuno
    • 1
  1. 1.Department of Obstetrics and GynecologyUniversity of TokyoJapan

Personalised recommendations